Top Markets
Coin of the day
Q-linea AB (publ) Q-linea AB (publ)

Q-linea AB (publ)

QLINEA
Rank in Stocks #31416
Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in... Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in developing diagnostic instruments and associated consumables for infection detection. The company crafts advanced in vitro diagnostic platforms, specifically engineered to identify infectious diseases. A key product is ASTar, an innovative system designed to rapidly assess antibiotic susceptibility in positive blood cultures. Q-linea's overarching mission is to deliver cutting-edge solutions to healthcare professionals.
Share Price
$2.22
Market Cap
$14.80M
Change (1 day)
14.37%
Change (1 year)
-59.91%
Country
SE
Trade Q-linea AB (publ) (QLINEA)

Category

Earnings for Q-linea AB (publ) (QLINEA)
Earnings in 2026 TTM: 0
According to Q-linea AB (publ) latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Q-linea AB (publ) from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH